OCT 18, 2016 12:30 PM PDT

Tools for the Interrogation of LRRK2 in Parkinson's Disease

Speaker

Abstract
The study of target-focused, disease relevant biology for drug discovery requires a comprehensive suite of tools that allow multiple aspects of the biology to be assessed.  Thermo Fisher Scientific has pioneered the development of such tools to study the role of the kinase LRRK2 in Parkinson’s Disease, from the first commercial production of full-length protein to enable biochemical assays, to tools that allow the generation and interrogation of dopaminergic neurons harboring disease-specific mutations.  This presentation will focus on how such tools can be used to better understand the disease, and accelerate the drug discovery process.
 

Show Resources
You May Also Like
OCT 29, 2020 6:00 AM PDT
C.E. CREDITS
OCT 29, 2020 6:00 AM PDT
Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
AUG 27, 2020 7:00 AM PDT
C.E. CREDITS
AUG 27, 2020 7:00 AM PDT
DATE: August 27, 2020 TIME: 7:00am PT Novel anti-viral medications, including biologics and small molecule inhibitors, as well as serologic diagnostic tool sets are in urgent demand to fight...
SEP 02, 2020 7:00 AM PDT
C.E. CREDITS
SEP 02, 2020 7:00 AM PDT
DATE: September 2, 2020 TIME: 03:00pm PDT, 6:00pm EDT Spatial omics is an expanding collection of methods to examine biological molecules in their geographical context. By retaining the prec...
DEC 02, 2020 8:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
DEC 02, 2020 8:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
NOV 18, 2020 8:00 AM PST
C.E. CREDITS
NOV 18, 2020 8:00 AM PST
DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
AUG 25, 2020 8:00 AM PDT
C.E. CREDITS
AUG 25, 2020 8:00 AM PDT
DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
Loading Comments...
Show Resources